Indivior Pharmaceuticals Ratios (2021-2026) | INDV

Ratios Dec2021 Dec2022 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin (Quarter) 86.62%73.58%78.50%83.61%83.08%82.78%73.25%81.56%87.38%
EBT Margin (Quarter) 25.70%-40.47%9.77%12.71%22.18%20.53%11.78%22.63%36.28%
EBIT Margin (Quarter) 26.41%-39.46%11.40%15.38%24.81%23.84%13.69%22.63%43.22%
EBITDA Margin (Quarter) 26.41%-39.46%11.40%15.38%24.81%23.84%13.69%22.63%43.22%
Operating Margin (Quarter) 26.41%-39.46%11.40%15.38%24.81%23.84%13.69%22.63%43.22%
Net Margin (Quarter) 21.83%-32.78%7.17%7.02%18.05%5.96%13.38%28.49%28.08%
FCF Margin (Quarter) -13.73%28.09%-1.63%-11.04%26.32%46.69%-18.79%-68.44%-9.15%
Efficiency
Inventory Average (Quarter) 104.50M120.00M165.00M156.00M152.00M154.00M152.50M
Assets Average (Quarter) 1,345.50M1,413.50M1,434.00M1,308.50M1,199.00M
Invested Capital (Quarter) 316.00M324.00M311.00M18.00M18.00M18.00M18.00M29.00M
Asset Utilization Ratio (Quarter) 0.870.830.820.951.08
Leverage & Solvency
Interest Coverage Ratio (Quarter) 8.33-13.113.183.545.504.803.5813.509.79
Debt Ratio (Quarter) 0.140.250.240.220.230.270.41
Times Interest Earned (Quarter) 8.33-13.113.183.545.504.803.5813.509.79
Valuation
Enterprise Value (Quarter) -1102.00M-893.00M-410.00M-320.00M-373.00M-510.00M-445.00M-195.00M-175.00M
Return Ratios
Return on Sales (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Capital Employed (Quarter) 8.52%61.26%48.40%66.41%79.29%
Return on Invested Capital (Quarter) 0.00%-0.01%0.03%0.02%0.03%0.04%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%0.00%